Why Your Metabolism Slows With Age
Why your metabolism slows
with age.
Metabolic decline is not simply about weight. It is a measurable biological shift in how your cells handle glucose, respond to insulin, and produce energy — and it begins earlier than most people realise.
Metabolic decline starts at the cellular level
Metabolism is not one system. It is the sum of thousands of enzymatic reactions occurring in every cell, governing how your body converts food into energy, stores fuel, regulates blood glucose, and responds to insulin signals.
With age, several interconnected changes impair this system. Mitochondrial efficiency declines, reducing the rate at which cells can oxidise glucose and fatty acids. Adipose tissue distribution shifts towards visceral fat, which promotes inflammation and disrupts insulin signalling. Skeletal muscle mass decreases, reducing the body's primary site of glucose disposal. And insulin receptor sensitivity progressively falls meaning the pancreas must produce more insulin to achieve the same glucose-lowering effect.[1]
The result is a state of progressive insulin resistance the central driver of metabolic syndrome, type 2 diabetes, cardiovascular disease, and accelerated biological ageing.
- Mitochondrial dysfunction: Ageing mitochondria produce less ATP per unit of substrate, increasing metabolic inefficiency and oxidative stress.
- Visceral fat accumulation: Adipose tissue shifts centrally with age, releasing inflammatory cytokines that directly impair insulin receptor signalling.
- Sarcopenia: Loss of skeletal muscle mass reduces glucose disposal capacity — muscle accounts for up to 80% of postprandial glucose uptake.
- Post-receptor signalling defects: Beyond receptor binding, downstream insulin signalling cascades become impaired, reducing GLUT4 translocation and glucose uptake into cells.[2]
“Insulin resistance progressively increases with age, resulting in excessively high incidence of type 2 diabetes in the elderly population. Mitochondrial dysfunction, intramyocellular lipid accumulation, increased inflammation, and sarcopenia may all impair skeletal muscle insulin sensitivity.”
Diabetology & Metabolic Syndrome, 2020 — DOI 10.1186/s13098-020-0523-xWhat metabolic decline actually affects
Age-related metabolic dysfunction does not stay contained to blood sugar. Its effects compound across four interconnected physiological systems.
Blood Glucose Regulation
Insulin resistance means cells respond less efficiently to insulin signals. Blood glucose rises higher after meals, stays elevated longer, and the pancreas works harder to compensate.
Cardiovascular Risk
Insulin resistance is independently associated with hypertension, dyslipidaemia, and endothelial dysfunction. Higher insulin resistance scores predict significantly elevated cardiovascular mortality risk.[1]
Energy and Fatigue
When cells cannot efficiently use glucose or fatty acids for fuel, energy production falters. This manifests as persistent fatigue, poor exercise tolerance, and difficulty recovering from physical exertion.
Cognitive Function
The brain relies on insulin signalling for glucose uptake. Insulin resistance is increasingly recognised as a driver of cognitive decline — with some researchers describing Alzheimer's as "type 3 diabetes".
This is not an inevitable part of ageing.
It is a modifiable one.
Metabolic syndrome defined by the presence of three or more of abdominal obesity, high blood pressure, elevated fasting glucose, high triglycerides, and low HDL cholesterol affects an estimated one quarter of global adults. Projections suggest this could rise to 53% by 2035.[3]
The biological drivers are real. But so is the evidence for intervention. Lifestyle modifications, targeted nutrition, and specific botanical compounds have demonstrated measurable effects on insulin sensitivity, fasting glucose, and metabolic markers in well-designed clinical trials.
What the clinical research on berberine shows
Berberine is a natural isoquinoline alkaloid with one of the most extensively studied metabolic profiles of any botanical compound. Its primary mechanism involves activation of AMPK (AMP-activated protein kinase) the same pathway activated by metformin which enhances glucose uptake in peripheral tissues, improves insulin sensitivity, and promotes metabolic efficiency.
Glucose-Lowering Effect of Berberine in Type 2 Diabetes (2022)
Berberine significantly reduced fasting plasma glucose by 0.82 mmol/L, HbA1c by 0.63%, and 2-hour postprandial glucose by 1.16 mmol/L vs placebo. Did not significantly increase adverse events or hypoglycaemia risk. PMID 36467075
Berberine Alone vs Conventional Treatment in Type 2 Diabetes
Berberine alone significantly reduced fasting plasma glucose (MD -0.59 mmol/L), 2-hour postprandial glucose (MD -1.57 mmol/L), LDL cholesterol, total cholesterol, and triglycerides. Effects confirmed across diverse populations. PMID 39640489
Berberine for Metabolic Profiles in Type 2 Diabetes
Significant reductions in HbA1c (MD -0.73%), fasting glucose (MD -0.86 mmol/L), insulin resistance (HOMA-IR MD -0.71), triglycerides, LDL, and total cholesterol. HDL increased. Strong evidence for efficacy and safety. PMID 34956436
Results from meta-analyses of RCTs. Individual results vary. Sources: PMID 36467075, PMID 39640489, PMID 34956436.
The Metabolic Reset Stack
Precision-formulated to support insulin sensitivity, blood sugar regulation, and metabolic efficiency — combining berberine, micronised creatine, and targeted metabolic support.
£47.99 or subscribe & save 15% · Free UK deliveryReferences
For informational purposes only. Not medical advice. Consult a qualified healthcare professional before supplementing.